5′ isomiR variation is of functional and evolutionary importance

Geok Chin Tan, Elcie Chan, Attila Molnár, +16

Nucleic Acids Research

Adjuvant mFOLFOX6 with or without cetuxiumab (Cmab) in KRAS wild-type (WT) patients (pts) with resected stage III colon cancer (CC): Results from NCCTG Intergroup Phase III Trial N0147.

Steven R. Alberts, Daniel J. Sargent, T. C. Smyrk, +7

Journal of Clinical Oncology

Kras Wild-typeCra3507 BackgroundSurgical OncologyGastrointestinal OncologyAdjuvant Mfolfox6 +12

MicroRNA signatures differentiate melanoma subtypes

Elcie Chan, Rajeshvari Patel, Sunitha Nallur, +12

Cell Cycle

EngineeringAggressive CancerPathologyMirna ArrayTumor Biology +16

A polymorphism in a <i>let‐7</i> microRNA binding site of <i>KRAS</i> in women with endometriosis

Olga Grechukhina, Rafaella Petracco, Shota Popkhadze, +6

EMBO Molecular Medicine

MedicineGeneticsUterine ReceptivityNatural SciencesHuman Polymorphism +8

Cryptic splice sites and split genes

Yuri Kapustin, Elcie Chan, Rupa Sarkar, +5

Nucleic Acids Research

Comparative GenomicsGeneticsRna SplicingMolecular BiologyMolecular Genetics +17

Adjuvant mFOLFOX6 plus or minus cetuximab (Cmab) in patients (pts) with KRAS mutant (m) resected stage III colon cancer (CC): NCCTG Intergroup Phase III Trial N0147.

Richard M. Goldberg, Daniel J. Sargent, S. N. Thibodeau, +7

Journal of Clinical Oncology

Surgical OncologyAdjuvant Mfolfox6ImmunologyPathologyArm D +14

α7 Nicotinic Acetylcholine Receptor Expression in Alzheimer's Disease: Receptor Densities in Brain Regions of the APP&lt;sub&gt;(SWE)&lt;/sub&gt; Mouse Model and in Human Peripheral Blood Lymphocytes

Ian W. Jones, Adam Westmacott, Elcie Chan, +4

Journal of Molecular Neuroscience

Synaptic TransmissionReceptor DensitiesSynaptic SignalingSocial SciencesAlzheimer's Disease +14

Quantifying the treatment goals of people recently diagnosed with schizophrenia using best&amp;ndash;worst scaling

John F. P. Bridges, Kathleen Beusterien, Stephan Heres, +5

Patient Preference and Adherence

Estrogen withdrawal, increased breast cancer risk and the KRAS-variant

Terri McVeigh, Song-Yi Jung, Michael J. Kerin, +16

Cell Cycle